Macarena Funes Chabán
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Macarena Funes Chabán has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Constantinos M. Athanassopoulos
Synthetic Organic Chemistry Laboratory, Department of Chemistry, University of Patras, GR-26504, Patras, Greece
1 shared publication - Dafni Graikioti
Synthetic Organic Chemistry Laboratory, Department of Chemistry, University of Patras, GR-26504, Patras, Greece
1 shared publication - Martina Hrast
Department of Pharmaceutical Chemistry Faculty of Pharmacy University of Ljubljana Ljubljana Slovenia
1 shared publication - María Cecilia Carpinella
Fine Chemical and Natural Products Laboratory, CIDIE CONICET-UCC, Universidad Católica de Córdoba, Córdoba X5016DHK, Argentina
1 shared publication - Rok Frlan
The Department of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Ljubljana, 1000 Ljubljana, Slovenia
1 shared publication
Latest Publications
- Open Access
- 15 December 2021
- Published by MDPI AG in Antibiotics
- Vol. 10 (12) , 1535
Inhibition of MurA Enzyme from Escherichia coli and Staphylococcus aureus by Diterpenes from Lepechinia meyenii and Their Synthetic Analogs
Enzymes MurA and MurF, involved in bacterial cell wall synthesis, have been validated as targets for the discovery of novel antibiotics. A panel of plant-origin antibacterial diterpenes and synthetic analogs derived therefrom were investigated for their inhibitory properties on these enzymes from Escherichia coli and Staphylococcus aureus. Six compounds were proven to be effective for inhibiting MurA from both bacteria, with IC50 values ranging from 1.1 to 25.1 µM. To further mechanistically investigate the nature of binding and to explain the activity, these compounds were docked into the active site of MurA from E. coli. The aromatic ring of the active compounds showed a T-shaped π–π interaction with the phenyl ring of Phe328, and at least one hydrogen bond was formed between the hydroxy groups and Arg120 and/or Arg91. The results disclosed here establish new chemical scaffolds for the development of novel entities targeting MurA as potential antibiotics to combat the threat of pathogenic bacteria, particularly resistant strains.
- 15 December 2021
- Published by MDPI AG in Antibiotics
- Vol. 10 (12) , 1535
Open AccessInhibition of MurA Enzyme from Escherichia coli and Staphylococcus aureus by Diterpenes from Lepechinia meyenii and Their Synthetic Analogs
Enzymes MurA and MurF, involved in bacterial cell wall synthesis, have been validated as targets for the discovery of novel antibiotics. A panel of plant-origin antibacterial diterpenes and synthetic analogs derived therefrom were investigated for their inhibitory properties on these enzymes from Escherichia coli and Staphylococcus aureus. Six compounds were proven to be effective for inhibiting MurA from both bacteria, with IC50 values ranging from 1.1 to 25.1 µM. To further mechanistically investigate the nature of binding and to explain the activity, these compounds were docked into the active site of MurA from E. coli. The aromatic ring of the active compounds showed a T-shaped π–π interaction with the phenyl ring of Phe328, and at least one hydrogen bond was formed between the hydroxy groups and Arg120 and/or Arg91. The results disclosed here establish new chemical scaffolds for the development of novel entities targeting MurA as potential antibiotics to combat the threat of pathogenic bacteria, particularly resistant strains.